Submission Details

Submitter:

Classification:
Disputed Evidence
GENCC:100005
Gene:
Disease:
RASopathy
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
02/04/2019
Evidence/Notes:

NSUN2 was first reported in relation to autosomal recessive RASopathies in 2012 (Martinez et al., PMID 22577224). At least 2 variants (e.g. frameshift, splice site) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data, and experimental data but only the mouse model supporting this association could be scored (PMIDs: 24102521, 22144916, 22577224). Variants in this gene have been reported in at least 2 probands in 2 publications (PMIDs 22577224, 24102521). Variants in this gene segregated with disease in 2 additional family members. This gene-disease association is supported by a mouse model indicating that homozygous deletion of the NSUN2 gene caused short stature and craniofacial anomalies (PMIDs: 22144916). However, the patients reported with NSUN2 variants did not possess convincing clinical features consistent with Noonan syndrome, despite the reports from Fahiminiya et al. 2014 suggesting that the condition was Noonan-like. Therefore, using the expert judgment of the ClinGen RASopathy Gene Curation Expert Panel these cases were not scored. In summary, the relationship between NSUN2 and autosomal recessive RASopathies is disputed. More evidence is needed to either support or refute the role NSUN2 plays in this disease. Additionally, this gene will be separately assessed by the ClinGen ID/Autism Gene Curation Expert Panel for complex neurodevelopmental disorder. This classification was approved by the ClinGen RASopathy Gene Curation Expert Panel on 2/4/2019 (SOP Version 5).

PubMed IDs:
22144916 22577224 24102521
Public Report:
Assertion Criteria:
Submitter Submitted Date:
12/05/2025

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.